Qube Research & Technologies (QRT) Portfolio holdings
Qube Research & Technologies (QRT) is a British investment firm that trades with computer-driven models and began life inside Credit Suisse. It started in late 2016 as the Qube Fund, run by the bank's asset management unit for model-based strategies, and used computer models to trade stocks. Credit Suisse planned to spin the fund off because rules such as the Volcker Rule restricted banks from trading with their own money, and at the start of 2018 its management team bought the unit and renamed it Qube Research & Technologies. It runs a mix of strategies across many regions, asset classes and time horizons, with research teams of engineers, physicists, mathematicians, data scientists and fundamental analysts.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$1.31B |
| 2 |
NVIDIA
NVDA
|
+$1.03B |
| 3 |
Meta Platforms (Facebook)
META
|
+$840M |
| 4 |
Shopify
SHOP
|
+$815M |
| 5 |
Caterpillar
CAT
|
+$639M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 2 |
Chevron
CVX
|
+$834M |
| 3 |
Sandisk
SNDK
|
+$632M |
| 4 |
Intercontinental Exchange
ICE
|
+$490M |
| 5 |
ExxonMobil
XOM
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.18% |
| 2 | Technology | 19.85% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.55% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2476
PUT
Expedia Group
EXPE
$30.6B
| $1.4M | ﹤0.01% |
5,300
-2,100
| -28% | -$611K |
2024 Q1
10 quarters
|
|
2477
Lyell Immunopharma
LYEL
$352M
| $1.39M | ﹤0.01% |
142,401
+31,870
| +29% | +$424K |
2025 Q4
3 quarters
|
|
2478
PUT
Sherwin-Williams
SHW
$84.5B
| $1.39M | ﹤0.01% |
4,300
+1,100
| +34% | +$372K |
2024 Q3
8 quarters
|
|
2479
PUT
Norwegian Cruise Line
NCLH
$8.25B
| $1.39M | ﹤0.01% |
94,700
-20,600
| -18% | -$361K |
2024 Q4
7 quarters
|
|
2480
First Tracks Biotherapeutics
TRAX
$1.98B
| $1.38M | ﹤0.01% |
38,937
+20,693
| +113% | +$808K |
2026 Q2
1 quarter
|
|
2481
PUT
Dollar General
DG
$29.6B
| $1.38M | ﹤0.01% |
11,500
-23,900
| -68% | -$2.95M |
2024 Q1
10 quarters
|
|
2482
AngioDynamics
ANGO
$499M
| $1.37M | ﹤0.01% |
+89,389
| New | +$1.33M |
2026 Q3
0 quarters
|
|
2483
iShares Core Dividend ETF
DIVB
$2.44B
| $1.37M | ﹤0.01% |
21,287
+14,683
| +222% | +$975K |
2025 Q3
4 quarters
|
|
2484
Immunic
IMUX
$103M
| $1.37M | ﹤0.01% |
+147,577
| New | +$2.03M |
2026 Q3
0 quarters
|
|
2485
Vanguard Morningstar Total Stock Market ETF
VTI
$689B
| $1.37M | ﹤0.01% |
3,657
+2,364
| +183% | +$886K |
2026 Q2
1 quarter
|
|
2486
NewtekOne
NEWT
$307M
| $1.36M | ﹤0.01% |
+122,555
| New | +$1.62M |
2026 Q3
0 quarters
|
|
2487
CALL
CSX Corp
CSX
$95.9B
| $1.36M | ﹤0.01% |
29,300
+26,100
| +816% | +$1.29M |
2024 Q4
7 quarters
|
|
2488
ProShares UltraPro Russell2000
URTY
$265M
| $1.36M | ﹤0.01% |
20,305
+20,188
| +17,255% | +$1.62M |
2025 Q4
3 quarters
|
|
2489
ACI Worldwide
ACIW
$6.09B
| $1.36M | ﹤0.01% |
+27,781
| New | +$1.49M |
2026 Q3
0 quarters
|
|
2490
PUT
Lennar Class A
LEN
$19.9B
| $1.35M | ﹤0.01% |
16,600
-8,800
| -35% | -$739K |
2023 Q4
11 quarters
|
|
2491
CALL
Phillips 66
PSX
$103B
| $1.35M | ﹤0.01% |
5,300
-3,800
| -42% | -$868K |
2024 Q3
8 quarters
|
|
2492
PUT
Prudential Financial
PRU
$42.4B
| $1.35M | ﹤0.01% |
11,900
-5,700
| -32% | -$680K |
2024 Q4
7 quarters
|
|
2493
Energy Services of America
ESOA
$163M
| $1.35M | ﹤0.01% |
120,859
+98,468
| +440% | +$1.33M |
2026 Q1
2 quarters
|
|
2494
VanEck Pharmaceutical ETF
PPH
$1.1B
| $1.34M | ﹤0.01% |
12,281
-34,255
| -74% | -$3.82M |
2026 Q1
2 quarters
|
|
2495
Trimble
TRMB
$12.8B
| $1.34M | ﹤0.01% |
+23,428
| New | +$1.33M |
2026 Q3
0 quarters
|
|
2496
Bank First Corp
BFC
$1.65B
| $1.34M | ﹤0.01% |
+8,987
| New | +$1.36M |
2026 Q3
0 quarters
|
|
2497
eGain
EGAN
$157M
| $1.33M | ﹤0.01% |
229,411
+7,956
| +4% | +$52.1K |
2026 Q1
2 quarters
|
|
2498
CALL
HubSpot
HUBS
$10.6B
| $1.33M | ﹤0.01% |
6,500
-3,000
| -32% | -$676K |
2025 Q2
5 quarters
|
|
2499
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.5B
| $1.33M | ﹤0.01% |
27,637
+16,685
| +152% | +$848K |
2025 Q1
6 quarters
|
|
2500
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.54B
| $1.33M | ﹤0.01% |
26,515
+18,835
| +245% | +$989K |
2026 Q1
2 quarters
|
|
Similar funds
Qube Research & Technologies (QRT)'s Q3 2026 Portfolio in Review
As of Q3 2026, Qube Research & Technologies (QRT) held 4,268 positions worth $123B, up 14% from $108B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $13.6B of net new capital in Q3 2026, opening 862 new positions and adding to 1,394 existing holdings. Its largest new stake was Caterpillar: 753,166 shares worth $611M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1B trimmed.
- Qube Research & Technologies (QRT)'s largest Q3 2026 buy was Caterpillar: 753,166 shares worth $611M.
- Qube Research & Technologies (QRT) added most to Warner Bros in Q3 2026, an estimated $1.31B increase.
- Qube Research & Technologies (QRT)'s biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1B.
- Qube Research & Technologies (QRT) fully exited Intercontinental Exchange in Q3 2026, selling an estimated $490M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $123B portfolio in Q3 2026.
- Qube Research & Technologies (QRT) opened 862 new positions and closed 641 in Q3 2026.
- Qube Research & Technologies (QRT)'s portfolio value rose 14% quarter-over-quarter to $123B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.